Bibliography
- Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015;131(4):e29–322
- Hossmann KA. Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol 2006;26(7-8):1057–83
- Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372(1):11–20
- Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359(13):1317–29
- O’Collins VE, Macleod MR, Donnan GA, et al. 1,026 experimental treatments in acute stroke. Ann Neurol 2006;59(3):467–77
- Stroke Therapy Academic Industry R. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999;30(12):2752–8
- Multi-PART Multicentre Preclinical Animal Research Team. 2014. Available from: http://www.dcn.ed.ac.uk/multipart/ [Cited 15 June 2015]
- Alvarez-Sabin J, Huertas R, Quintana M, et al. Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 2007;38(3):1076–8
- Montaner J, Chacon P, Krupinski J, et al. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol 2008;15(1):82–90
- Arrich J, Holzer M, Havel C, et al. Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev 2012;9:CD004128
- EuroHYP-1. 2015. Available from: http://www.eurohyp1.eu/ [Cited 15 June 2015]
- Hill MD, Martin RH, Mikulis D, et al. Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2012;11(11):942–50
- Zhang M, Wang S, Mao L, et al. Omega-3 fatty acids protect the brain against ischemic injury by activating Nrf2 and upregulating heme oxygenase 1. J Neurosci 2014;34(5):1903–15
- Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013;368(14):1279–90
- Mori M, Mori H, Hamada A, Yamori Y. Taurine in morning spot urine for the useful assessment of dietary seafood intake in Japanese children and adolescents. J Biomed Sci 2010;17(Suppl 1):S43
- Virtanen JK, Siscovick DS, Longstreth WTJr, et al. Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology 2008;71(6):439–46
- Toh JY, Tan VM, Lim PC, et al. Flavonoids from fruit and vegetables: a focus on cardiovascular risk factors. Curr Atheroscler Rep 2013;15(12):368
- Kaneko Y, Cortes L, Sanberg C, et al. Dietary Supplementations as Neuroprotective Therapies: Focus on NT-020 Diet Benefits in a Rat Model of Stroke. Int J Mol Sci 2012;13(6):7424–44
- Wang Y, Chang CF, Chou J, et al. Dietary supplementation with blueberries, spinach, or spirulina reduces ischemic brain damage. Exp Neurol 2005;193(1):75–84
- Leonardo CC, Dore S. Dietary flavonoids are neuroprotective through Nrf2-coordinated induction of endogenous cytoprotective proteins. Nutr neurosci 2011;14(5):226–36
- Wang X, Figueroa BE, Stavrovskaya IG, et al. Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are neuroprotective in experimental models of ischemic injury. Stroke 2009;40(5):1877–85
- Boutin H, LeFeuvre RA, Horai R, et al. Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci 2001;21(15):5528–34
- Dhungana H, Rolova T, Savchenko E, et al. Western-type diet modulates inflammatory responses and impairs functional outcome following permanent middle cerebral artery occlusion in aged mice expressing the human apolipoprotein E4 allele. J Neuroinflammation 2013;10:102